These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 24760019

  • 1. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.
    Sahlberg SH, Spiegelberg D, Glimelius B, Stenerlöw B, Nestor M.
    PLoS One; 2014; 9(4):e94621. PubMed ID: 24760019
    [Abstract] [Full Text] [Related]

  • 2. Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
    Chen KL, Pan F, Jiang H, Chen JF, Pei L, Xie FW, Liang HJ.
    Clin Exp Metastasis; 2011 Dec; 28(8):751-63. PubMed ID: 21750907
    [Abstract] [Full Text] [Related]

  • 3. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
    Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, Gottesman MM, Varticovski L, Ambudkar SV.
    J Natl Cancer Inst; 2010 Nov 03; 102(21):1637-52. PubMed ID: 20935265
    [Abstract] [Full Text] [Related]

  • 4. Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma.
    Choi D, Lee HW, Hur KY, Kim JJ, Park GS, Jang SH, Song YS, Jang KS, Paik SS.
    World J Gastroenterol; 2009 May 14; 15(18):2258-64. PubMed ID: 19437567
    [Abstract] [Full Text] [Related]

  • 5. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N, Ishii H, Mimori K, Ohta K, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M.
    Int J Oncol; 2013 Aug 14; 43(2):425-30. PubMed ID: 23708747
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
    Wang C, Xie J, Guo J, Manning HC, Gore JC, Guo N.
    Oncol Rep; 2012 Oct 14; 28(4):1301-8. PubMed ID: 22895640
    [Abstract] [Full Text] [Related]

  • 7. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE.
    PLoS One; 2011 Oct 14; 6(6):e20636. PubMed ID: 21695188
    [Abstract] [Full Text] [Related]

  • 8. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG, Mele V, Däster S, Han J, Heberer M, Cesare Spagnoli G, Iezzi G.
    Stem Cells Transl Med; 2012 Aug 14; 1(8):592-603. PubMed ID: 23197865
    [Abstract] [Full Text] [Related]

  • 9. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
    Peng L, Xiong Y, Wang R, Xiang L, Zhou H, Gu H.
    Biosci Rep; 2020 Aug 28; 40(8):. PubMed ID: 32729895
    [Abstract] [Full Text] [Related]

  • 10. Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation.
    Shimozato O, Waraya M, Nakashima K, Souda H, Takiguchi N, Yamamoto H, Takenobu H, Uehara H, Ikeda E, Matsushita S, Kubo N, Nakagawara A, Ozaki T, Kamijo T.
    Oncogene; 2015 Apr 09; 34(15):1949-60. PubMed ID: 24882578
    [Abstract] [Full Text] [Related]

  • 11. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
    Zhang Y, Wei J, Wang H, Xue X, An Y, Tang D, Yuan Z, Wang F, Wu J, Zhang J, Miao Y.
    Oncol Rep; 2012 May 09; 27(5):1599-605. PubMed ID: 22322379
    [Abstract] [Full Text] [Related]

  • 12. Expression of gastrin precursors by CD133-positive colorectal cancer cells is crucial for tumour growth.
    Ferrand A, Sandrin MS, Shulkes A, Baldwin GS.
    Biochim Biophys Acta; 2009 Mar 09; 1793(3):477-88. PubMed ID: 19321126
    [Abstract] [Full Text] [Related]

  • 13. CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers.
    Chen J, Guo T, Zhang L, Qin LX, Singer S, Maki RG, Taguchi T, Dematteo R, Besmer P, Antonescu CR.
    Genes Chromosomes Cancer; 2012 Feb 09; 51(2):186-95. PubMed ID: 22076958
    [Abstract] [Full Text] [Related]

  • 14. Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker.
    Schneider M, Huber J, Hadaschik B, Siegers GM, Fiebig HH, Schüler J.
    BMC Cancer; 2012 Mar 20; 12():96. PubMed ID: 22433494
    [Abstract] [Full Text] [Related]

  • 15. Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells.
    Wu S, Wang X, Chen J, Chen Y.
    Biochem Biophys Res Commun; 2013 May 17; 434(4):898-903. PubMed ID: 23624503
    [Abstract] [Full Text] [Related]

  • 16. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.
    Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L.
    Breast Cancer Res; 2008 May 17; 10(1):R10. PubMed ID: 18241344
    [Abstract] [Full Text] [Related]

  • 17. Integrin-EGFR interaction regulates anoikis resistance in colon cancer cells.
    Guha D, Saha T, Bose S, Chakraborty S, Dhar S, Khan P, Adhikary A, Das T, Sa G.
    Apoptosis; 2019 Dec 17; 24(11-12):958-971. PubMed ID: 31641961
    [Abstract] [Full Text] [Related]

  • 18. CD133+CD44+ population efficiently enriches colon cancer initiating cells.
    Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F, Mimori K, Kamohara Y, Inoue H, Mori M.
    Ann Surg Oncol; 2008 Oct 17; 15(10):2927-33. PubMed ID: 18663533
    [Abstract] [Full Text] [Related]

  • 19. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
    Hou YC, Chao YJ, Tung HL, Wang HC, Shan YS.
    Cancer; 2014 Sep 01; 120(17):2766-77. PubMed ID: 24839953
    [Abstract] [Full Text] [Related]

  • 20. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
    Wakamatsu Y, Sakamoto N, Oo HZ, Naito Y, Uraoka N, Anami K, Sentani K, Oue N, Yasui W.
    Pathol Int; 2012 Feb 01; 62(2):112-9. PubMed ID: 22243781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.